Utang jangka dawa marang ekuitas are.com (ARE)

The price trend shown below illustrates the dynamics of Alexandria (ARE), whose business model relies on leadership in the high-tech biopharmaceutical and research institute space. Alexandria creates sustainable barriers for competitors in the largest US scientific hubs, where the indicator is 0.84. Strong pricing power is driven by inelastic demand for laboratories, while long-term agreements with industry behemoths guarantee a stable cash flow with no signs of decline.

For Alexandria (ARE), which develops high-tech biopharmaceutical campuses, the ratio of long-term debt to equity reflects its financing strategy for capital-intensive R&D projects. This indicator is calculated as the ratio of liabilities with a maturity exceeding one year to total equity, allowing investors to assess the level of credit leverage and the stability of the fund's long-term asset financing structure.